Trust is harder to earn in the GLP-1 space now. I gave more weight to named pharmacies, visible prescribing standards, realistic pricing, and programs that explain the tradeoffs instead of hiding them.
The loudest names in telehealth weight loss are not always the most trustworthy ones. After the FDA sent warning letters to more than 30 compounding and telehealth firms in early 2026, it became clear that brand recognition and genuine accountability are two very different things. What follows is a shortlist built around pharmacy transparency, pricing honesty, clinical oversight, and real-world access, not marketing spend.
1. HealthRX
Start here if you want compounded GLP-1 medication at a genuinely low cash price, shipped overnight, with a named pharmacy behind every vial.
HealthRX works like this: you complete an online health assessment, a US board-certified physician reviews it within roughly 24 hours, and your medication ships the same day a prescription is issued. Free overnight delivery to all 50 states. No hidden fees, no subscription tiers that inflate the real cost.
The pricing holds up to comparison. Compounded semaglutide opens at $99 per month; compounded tirzepatide opens at $149. For cash-pay telehealth, that sits at the low end of the market, not because anything is cut, but because the model is direct.
What earns trust here is specificity. Medication is dispensed through Manifest Pharmacy in Greer, South Carolina, a 503A compounding pharmacy operating under USP-797 standards with lot-tracked inventory from bench to delivery. Manifest carries LegitScript certification (certificate 50087439). That is a publicly verifiable number. Many telehealth providers name a pharmacy only in fine print, or not at all.
The clinical numbers HealthRX references come from published trials: the SURMOUNT-1 study showed approximately 21% body weight reduction with tirzepatide at 72 weeks; the STEP 1 trial showed roughly 15% with semaglutide at 68 weeks. These are trial outcomes, not guarantees from any individual provider.
One honest caveat applies to HealthRX and every entry on this list: compounded medications are produced outside the FDA’s finished drug approval process. They are legal under 503A pharmacy rules, but that distinction matters and any provider who glosses over it should lose points for it.
2. FormBlends
FormBlends runs a similar compounded GLP-1 model with physician oversight and a 503A-registered pharmacy behind its dispensing. What it adds is published purity documentation: HPLC purity percentages, mass spec identity confirmation, endotoxin and sterility results, named per product. Most telehealth-only GLP-1 brands do not publish that level of batch testing in any findable form.
Cash pricing runs higher than HealthRX. Semaglutide is around $299 per vial; tirzepatide around $349. Ships to 47 states, not 50. If those tradeoffs feel acceptable, the transparency on testing data is a real differentiator.
FormBlends also carries a broader peptide catalog covering recovery, cognitive, and longevity compounds under the same clinician framework. That matters to a specific type of customer who wants GLP-1s and other peptide protocols from one provider rather than managing two separate telehealth relationships.
The honest read: FormBlends is not the value pick. HealthRX wins on price and geographic reach. But if published purity data or a wider compound catalog matters to you, FormBlends earns its place on a shortlist.
3. Mochi Health
Mochi Health uses board-certified obesity-medicine clinicians, which is not the norm across this category. Most platforms use general practitioners or nurse practitioners prescribing to protocol. Monthly cash pricing lands at roughly $99 for semaglutide and $199 for tirzepatide. Monitoring is heavier than most budget-tier options.
4. Hims & Hers
A big, publicly traded company. After the March 2026 Novo Nordisk settlement, Hims & Hers exited compounded semaglutide and shifted to branded medications. Injectable Wegovy is around $299 per month through their platform; oral semaglutide around $249; Zepbound around $399. With insurance and a manufacturer savings card, out-of-pocket cost can drop to as low as $0 to $25 for eligible patients. Strong app experience, wide name recognition.
5. Ro Body
Ro’s GLP-1 program starts at $39 for the first month, then $74 to $149 per month for the platform fee, with medication billed separately. They have a prior-authorization team that works to get branded GLP-1s covered by insurance, which is worth something if you have commercial insurance and the patience for that process.
6. Henry Meds
Henry Meds keeps things simple. Cash-pay compounded GLP-1s, pricing around $179 to $249 for the first month, fast shipping in the 24 to 72 hour range. Lighter on monitoring than Mochi, but faster to start. Good fit for patients who already have a primary care relationship and just need the medication pathway.
7. PlushCare
PlushCare works differently from most entries here. It is a general telehealth platform, not a GLP-1 specialist. Membership runs $19.99 per month with same-day appointments available. It accepts insurance for branded medications, which matters if your plan covers Wegovy or Zepbound and you would rather work within that system than pay cash for a compound.
8. Form Health
Form Health is the premium end of this market. Around $299 per month, that fee covers not just prescribing but a dedicated MD and a registered dietitian working together on your case, plus lab work. If you want a full clinical program rather than a medication subscription, Form Health is the most structured option on this list. It is not for people primarily looking to save money.
9. Found
Found charges roughly $99 per month for the platform, with medications billed on top. Coaching is included. It is a reasonable middle-ground option for someone who wants more support than a pure prescription-delivery service but is not ready for the cost of Form Health. The platform is well-established and has been in this space longer than most.
How to Actually Read This List
Price alone is a bad filter. A $99 per month semaglutide subscription from a provider with no named pharmacy and no verifiable certifications is not the same product as $99 per month from one with a documented 503A compounding facility and LegitScript certification.
The questions worth asking any provider: Who is the dispensing pharmacy? What standards does it operate under? Is the physician review a real clinical step or a checkbox? Is pricing shown upfront, total, before you hand over a card number?
Most of the names on this list answer those questions adequately. A few answer them better than the rest.
Common Questions
What actually makes one GLP-1 telehealth provider safer than another?
The biggest dividing line is pharmacy accountability. A provider that names its dispensing pharmacy, cites the operating standard (USP-797 for sterile injectables), and carries a verifiable certification like LegitScript gives you something to check. One that ships medication without disclosing any of that gives you nothing to verify if something goes wrong.
Is compounded semaglutide or tirzepatide the same drug as Wegovy or Zepbound?
No, and that distinction is worth understanding before you order. Compounded versions contain the same active ingredient but are manufactured by 503A pharmacies outside the FDA’s finished drug approval process. They are legal and widely used, but they have not gone through the same pre-market review as the branded products from Novo Nordisk and Eli Lilly.
After Hims & Hers stopped offering compounded semaglutide in 2026, which providers still offer compounded options?
As of mid-2026, HealthRX, FormBlends, Mochi Health, and Henry Meds are among the providers on this list still offering compounded GLP-1s at cash prices. Hims & Hers shifted to branded medications following its March 2026 settlement with Novo Nordisk. Availability can change, so confirm directly with any provider before starting.
How do I know if a telehealth provider’s physician review is a real clinical step or just a checkbox?
Ask before you pay. A real clinical review means a physician looks at your health history, flags contraindications, and may follow up with questions. Signs it is a checkbox: instant approvals at any hour, no follow-up questions regardless of what you entered, and no mechanism to reach the prescriber afterward. Mochi Health and Form Health are noted for heavier oversight; budget-tier platforms vary widely.
Does any provider on this list help with insurance coverage for branded GLP-1s?
Yes. Ro Body has a prior-authorization team specifically set up to pursue insurance coverage for branded medications like Wegovy and Zepbound, which is useful if you have commercial insurance. PlushCare also accepts insurance for branded prescriptions. Both require patience, since prior-auth timelines vary by insurer and plan type.
*Pricing reflects publicly available figures as of mid-2026 and may change. Compounded medications are produced outside the FDA’s finished drug approval process.*
Sources
- FDA, warning letters to telehealth and compounding firms, early 2026 (FDA.gov)
- Novo Nordisk settlement announcement, March 9 2026 (publicly reported)
- SURMOUNT-1 trial (Jastreboff et al., New England Journal of Medicine, 2022)
- STEP 1 trial (Wilding et al., New England Journal of Medicine, 2021)
- LegitScript certification lookup (LegitScript.com)
- USP-797 pharmaceutical compounding standards (USP.org)
- Lilly, orforglipron pricing via LillyDirect, April 2026 (publicly reported)
